A new conception of palliative care in Oncology: Continue care and level integration;Una nueva concepción de los cuidados paliativos en Oncología: los cuidados continuos y la integración de niveles

Clinical and Translational Oncology

Volumn 4, Issue 9, 2002, Pages 476-484

  Herrero, Carlos Camps ^a   Banaclocha, Natividad Martínez ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Medical Oncology; Palliative care; Supportive care; Terminal patient

Indexed keywords

EID: 84873689100     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. McKean-Cowdin R, Spencer H, Ross R, Pike M, Henderson B. Declining cancer rates in the 1990s. J Clin Oncol 2000;18: 2258-68.
2. Radu B, Cole P. The fifty-year decline of cancer in America. J Clin Oncol 2001;19:239-41.
3. Coebergh J, Sant M, Berrino F, Verdecchia A. Survival of adult cancer patients in Europe diagnosed from 1978-1989: the Eurocare II study. Eur J Cancer 1998;34: 2137-278.
4. Cancer care during de last phase of life. Adopted on 20 February 1998 by the American Society of Clinical Oncology. J Clin Oncol 1998;16:1986-96.
5. Picaza J, Serra-Prat M, Gallo P. El consumo de recursos de los enfermos oncológicos durante el último mes de vida: el papel de los PADES. Breu AATM, BR05, 2000:1-12.
6. Addington-Hall JM, MacDonald LD, Anderson HR, et al. Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. BMJ 1992;305: 1317-22.
7. Boletín del Colegio Oficial de Médicos de Valencia. Estu-dio de la población colegiada por especialidades. Rev Consejo General Colegios Médicos España 2001; 74: 8-10.
8. Hillner B, Smith T, Desch C. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 2000;18:2327-40.
9. De las Heras B, Vilches Y, Ordoñes A, Jiménez-Gordo M, de Castro J, González-Barón M. Cuidados paliativos en Oncología: pasado y presente. Oncología 2000; 23: 256-61.
10. Field D, James N. Where and how people die. En: Clark D, editor. The future of palliative care. Buckingham: Open University Press; 1993. p. 6-29.
11. Gonzalez-Barón J, García de Paredes M, Berrocal A, Or-dóñez A. Tratamiento paliativo del paciente terminal. Rev Cáncer 2000;14:1-7.
12. Hanson LC, Tulsky JA, Danis M. Can clinical interventions change care at the end of life? Ann Intern Med 1997; 126:381-8.
13. Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med 1998; 12:317-22.
14. Ordóñez Gallego A, González Barón M, Feliu Batlle J, et al. Tratamiento de soporte en el enfermo con cáncer. Al-gunas propuestas basadas en nuestra experiencia. Rev Oncología 2001;3:266-9.
15. Hopwood P, Stephens R. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000;18:893-903.
16. Billings JA. What is palliative care? J Palliat Med 1998;1: 73-81.
17. Stiefel F, Guex P. Cuidados paliativos y de soporte. Ann Oncol (ed. esp.) 1996;4:321-4.
18. Smith TJ, Swisher K. Telling the truth about terminal cancer (editorial). JAMA 1998;21:1746-8.
19. Hinton J. Which patients with terminal cancer are admitted from home care? Palliat Med 1994;8:197-210.
20. Macdonald N. The interface between oncology and palliative medicine. En: Doyle D, Hanks GWC, MacDonald N, editores. Oxford textbook of palliative medicine. Oxford: Oxford University Press; 1997. p. 11-7.
21. Tsamandouraki K, Tountas Y, Trichopoulos D. Relative survival of terminal cancer patients in home versus hospital care. Scand J Soc Med 1992;20:51-4.
22. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. Adopted on 24 July 1995 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:671-9.
23. Maltoni M, Amadori D. Medicina paliativa y oncología médica. Ann Oncol 2001;10:700-7.
24. Hughes SL, Cummings J, Weaver F, Manheim L, Braun B, Conrad K. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill. Health Services Research 1992; 26:801-17.
25. Earle C, Baker C, Stone P, Sandberg E, Neumann P. Systematic overview of cost-utility assessments in oncology. J Clin Oncol 2000;18:3302-17.
26. Cummings JE, Hughes SL, Weaver FM, et al. Cost-effectiveness of veterans administration hospital-based home care. A randomized clinical trial. Arch Intern Med 1990; 150:1274-80.
27. Mor V, Kidder D. Cost savings in hospice: final results of the national hospice study. Health Services Research 1985; 20:407-22.
28. Greer DS, Mor V, Morris JN, Sherwood S, Kidder D, Birnbaum H. An alternative in terminal care: results of the national hospice study. J Chronic Dis 1986;39:9-20.
29. Lang Meier M, Neuenschwander H. Hospice a homecare service for terminally ill patients in southern Switzerland. Support Care Cancer 1995;3:389-92.
30. Seale C. A comparison of hospice and conventional care. Soc Sci Med 1991;32:147-52.
31. Dunlop RJ, Davies RJ, Hockley JM. Preferred versus actual place of death: a hospital palliative care support team experience. Palliat Med 1989;3:197-201.
32. Wallston KA, Burger C, Smith RA, Baugher RJ. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care 1988; 26: 177-82.
33. Cantwell P, Turco S, Brenneis C, Neumann CM, Bruera E. Predictors of home death in palliative care cancer patients. Journal of Palliative Care 2000;16:23-8.
34. Smeenk FW, van Haagstregt JC, de Witte LP, Crebolder H F. Effectiveness of home care programmes for patients with incurable cancer on their quality of life and times spent in hospital: systematic review. BMJ 1998;316: 1939-44.
35. Grande GE, Todd CJ, Barclay SIG, Farquhar MC. Does hospital at home for palliative care facilitate death at home? Randomised controlled trial. BMJ 1999;319:1472-5.
36. Billings JA, Block SD. Palliative care in undergraduate medical education: status report and future directions. JAMA 1997;278:733-8.
37. Jones RV, Hansford J, Fiske J. Death from cancer at home: the carers' perspective. BMJ 1993;306:249-51.
38. Townsend J, Frank AO, Fermont D, et al. Terminal cancer care and patients' preference for place of death: a prospective study. BMJ 1990;301:415-7.
39. Krakauer E, Penson RT, Truog RD, King LA, Chabner BA, Lynch TJ. Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist 2000; 5: 53-62.
40. Raftery JP, Addington-Hall JM, MacDonald LD, et al. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients. Palliat Med 1996;10:151-61.
41. Heimann R, Hellman S. Clinical progression of breast cancer malingnant behavior: what to expect and when to expect it. J Clin Oncol 2000;18:591-9.
42. Sanz J, Rivera F, Ferré A, Vega ME. Tratamiento onco-lógico activo de la enfermedad neoplásica y avanzada terminal. Med Clin 2000;114(8):302-7.
43. Leydon G, Boulton B, Moynihan C, et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ 2000;320:909.
44. Proyecto de Real Decreto. Plan Nacional de Cuidados Pa-liativos: bases para su desarrollo.
45. McWhinney IR, Bass MJ, Donner A. Evaluation of a palliative care service: problems and pitfalls. BMJ 1994; 309:1340-2.
46. Zimmer JG, Groth-Juncker A, McCusker J. A randomized controlled study of a home health care team. Am J Public Health 1985;75:134-41.
47. Bajorin D, Dadd P, Mazumdar, et al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 1999; 17:3173-81.
48. Geels P, Eisenhauer E, Bezjaak A, Zee B, Day A. Palliative effect of chemotherapy: objetive tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 2000;18:2395-405.
49. Archer V, Cullen M. Palliative chemotherapy. No longer a contradiction in terms. The Oncologist 1999;4:470-7.
50. Baile WF, Kudelka AP, Beale EA, et al. Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness. Cancer 1999;86:887-97.
51. Stiggelbout A, Haes J. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol 2001;19:220-30.
52. Weeks JC, Cook FE, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;21:1709-14.
53. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998;317:771-5.
54. List M, Stracks J, Colangelo L, et al. How do head and neck cancer patients prioritise treatment outcomes before initiating treatment? J Clin Oncol 2000;18:877-84.
55. Rabow MW, Hardie GE, Fair JM, McPhee SJ. End-of-life care content in 50 textbooks from multiple specialties. JAMA 2000;283:771-8.
56. Mandelblatt J, Ganz P, Kahn K. Proposed agenda for the measurement of quality of care outcomes in oncology practice. J Clin Oncol 1999;17:2614-22.
57. O'Hare PA, Yost LS, McCorkle R. Strategies to improve continuity of care and decrease rehospitalization of cancer patients: a review. Cancer Invest 1993;11:140-58.
58. McQuay H, Moore A. Need for rigorous assessment of palliative care. BMJ 1994;309:1315-6.